Clinical Trials for Pheochromocytoma

Find clinical trials for pheochromocytoma. Discover research opportunities and treatment options in your area.

30 Active Trials Found

Showing 30 trials on this page

Page 1 of 2

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT ID: NCT06503146

This clinical trial is studying a new imaging method using a special substance called 18F-FAPI-74 to help detect certain types of cancer more effectively. The goal is to find out if this new tracer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

NCT ID: NCT06427798

This clinical trial is studying a new treatment called \[212Pb\]VMT-alpha-NET for adults with specific types of cancer called gastrointestinal neuroendocrine tumors (GI NET) or pheochromocytomas/pa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

NCT ID: NCT05702944

This clinical trial is investigating whether patients with normotensive pheochromocytoma (a type of tumor) can safely skip a certain pre-surgery medication called alpha-adrenergic blockade. Traditi...

Recruiting

Phase: PHASE4 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

NCT ID: NCT03206060

This clinical trial is studying a new treatment called Lu-177-DOTATATE (also known as Lutathera) for patients with pheochromocytoma and paraganglioma, which are rare tumors that can be difficult to...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States, San Francisco, California, United States +1 more

Diagnosis of Pheochromocytoma

NCT ID: NCT00004847

This clinical trial is focused on improving the diagnosis and treatment of pheochromocytomas, which are tumors that typically develop in the adrenal glands and can cause serious health problems lik...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma

NCT ID: NCT06429397

This clinical trial is exploring the use of two medications, anlotinib and penpulimab, to treat patients with advanced pheochromocytoma, a rare type of tumor that affects the adrenal glands. Curren...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

NCT ID: NCT00107289

This clinical trial is studying a treatment called Iodine I 131 Metaiodobenzylguanidine (131 I-MIBG) for patients with difficult-to-treat neuroblastoma, malignant pheochromocytoma, or paraganglioma...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States

Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT ID: NCT04119024

This clinical trial is testing a new treatment for patients with advanced melanoma and other types of solid tumors that have spread in the body. The treatment involves using specially modified immu...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States, Los Angeles, California, United States +1 more

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

NCT ID: NCT03541720

This clinical trial is studying a new imaging technique using a special substance called 18F-fluorodopamine (18F-DA) to help doctors better see and analyze tumors in children with neuroblastoma and...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Memphis, Tennessee, United States

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

NCT ID: NCT06813742

This clinical trial is studying a special imaging test called 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) to see how well it can help doctors evaluate and measure ph...

Recruiting

Type: observational Locations: Hangzhou, Zhejiang, China, Hangzhou, Zhejiang, China

Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

NCT ID: NCT05636618

This clinical trial is testing a new treatment called \[212Pb\]VMT-α-NET, which uses targeted alpha-particle therapy for patients with advanced neuroendocrine tumors (NETs) that express a specific ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Columbus, Ohio, United States +12 more

Hereditary Pheochromocytoma Assessment of Tumour Immunologies

NCT ID: NCT06444607

This clinical trial is studying how the immune system relates to two types of tumors called pheochromocytomas and paragangliomas, which can be hereditary (passed down in families). The researchers ...

Recruiting

Type: observational Locations: Nijmegen, Gelderland, Netherlands

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT ID: NCT06607692

This clinical trial, called LuPARPed, is studying a combination treatment for children and adolescents with certain types of solid tumors that have come back or have not responded to previous treat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boadilla Del Monte, Madrid, Spain

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

NCT ID: NCT03160274

This clinical trial is studying genetic factors related to pheochromocytomas and paragangliomas, which are types of tumors that can affect the nervous system and are often inherited. The researcher...

Recruiting

Type: observational Locations: San Antonio, Texas, United States

Institutional Registry of Rare Diseases

NCT ID: NCT06573723

This clinical trial, called the Institutional Registry of Rare Diseases, aims to gather information about various rare diseases, including conditions like amyloidosis, sarcoidosis, and Wilson disea...

Recruiting

Type: observational Locations: Buenos Aires, , Argentina

"Receptor Radionuclide Therapy With 177Lu-DOTATOC

NCT ID: NCT06045260

This clinical trial is studying a treatment called Receptor Radionuclide Therapy (PRRT) using a substance known as 177Lu-DOTATOC for patients with certain types of neuroendocrine tumors, as well as...

Recruiting

Phase: PHASE2 Type: interventional Locations: Meldola, Forlì Cesena, Italy, Meldola, , Italy +2 more

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

NCT ID: NCT05636540

This clinical trial is looking at a special type of imaging called 18F-FluorThanatrace PET/CT to see how a protein called PARP-1 behaves in patients with pheochromocytoma or paraganglioma, which ar...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

NCT ID: NCT06523582

This clinical trial is focused on understanding the genetic factors that cause neuroendocrine neoplasms (NENs) in Mexican patients. NENs are tumors that can develop in various organs and may produc...

Recruiting

Type: observational Locations: Mexico City, Cdmx, Mexico, Mexico City, Cdmx, Mexico +1 more

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

NCT ID: NCT06377033

This clinical trial, titled "Using the EHR to Advance Genomic Medicine Across a Diverse Health System," is exploring a new way to make genetic testing more accessible and useful for patients with c...

Recruiting

Phase: NA Type: interventional Locations: Philadelphia, Pennsylvania, United States

The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)

NCT ID: NCT06440122

This clinical trial is investigating the presence and effects of a special type of fat called metabolically active brown adipose tissue (aBAT) in patients with pheochromocytoma or paraganglioma, wh...

Recruiting

Type: observational Locations: London, , United Kingdom, London, , United Kingdom

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions